ResMed Net Profit Margin 2010-2024 | RMD
Current and historical net profit margin for ResMed (RMD) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. ResMed net profit margin for the three months ending September 30, 2024 was .
| ResMed Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-09-30 | $4.81B | $1.11B | 23.13% |
| 2024-06-30 | $4.69B | $1.02B | 21.77% |
| 2024-03-31 | $4.58B | $0.96B | 20.90% |
| 2023-12-31 | $4.50B | $0.89B | 19.78% |
| 2023-09-30 | $4.38B | $0.91B | 20.73% |
| 2023-06-30 | $4.22B | $0.90B | 21.26% |
| 2023-03-31 | $4.02B | $0.86B | 21.49% |
| 2022-12-31 | $3.76B | $0.81B | 21.49% |
| 2022-09-30 | $3.63B | $0.79B | 21.68% |
| 2022-06-30 | $3.58B | $0.78B | 21.79% |
| 2022-03-31 | $3.54B | $0.78B | 22.03% |
| 2021-12-31 | $3.44B | $0.52B | 15.19% |
| 2021-09-30 | $3.35B | $0.50B | 14.96% |
| 2021-06-30 | $3.20B | $0.48B | 14.86% |
| 2021-03-31 | $3.09B | $0.46B | 14.82% |
| 2020-12-31 | $3.09B | $0.70B | 22.61% |
| 2020-09-30 | $3.03B | $0.68B | 22.46% |
| 2020-06-30 | $2.96B | $0.62B | 21.04% |
| 2020-03-31 | $2.89B | $0.51B | 17.74% |
| 2019-12-31 | $2.78B | $0.46B | 16.34% |
| 2019-09-30 | $2.70B | $0.42B | 15.52% |
| 2019-06-30 | $2.61B | $0.41B | 15.54% |
| 2019-03-31 | $2.53B | $0.45B | 17.66% |
| 2018-12-31 | $2.46B | $0.45B | 18.37% |
| 2018-09-30 | $2.41B | $0.34B | 13.97% |
| 2018-06-30 | $2.34B | $0.32B | 13.50% |
| 2018-03-31 | $2.27B | $0.31B | 13.54% |
| 2017-12-31 | $2.20B | $0.29B | 13.02% |
| 2017-09-30 | $2.13B | $0.35B | 16.61% |
| 2017-06-30 | $2.07B | $0.34B | 16.60% |
| 2017-03-31 | $2.03B | $0.32B | 15.98% |
| 2016-12-31 | $1.97B | $0.33B | 16.62% |
| 2016-09-30 | $1.89B | $0.35B | 18.28% |
| 2016-06-30 | $1.84B | $0.35B | 19.18% |
| 2016-03-31 | $1.77B | $0.36B | 20.12% |
| 2015-12-31 | $1.74B | $0.36B | 20.49% |
| 2015-09-30 | $1.71B | $0.35B | 20.58% |
| 2015-06-30 | $1.68B | $0.35B | 20.98% |
| 2015-03-31 | $1.64B | $0.35B | 21.52% |
| 2014-12-31 | $1.62B | $0.35B | 21.78% |
| 2014-09-30 | $1.58B | $0.35B | 22.07% |
| 2014-06-30 | $1.56B | $0.35B | 22.25% |
| 2014-03-31 | $1.56B | $0.33B | 21.29% |
| 2013-12-31 | $1.54B | $0.33B | 21.16% |
| 2013-09-30 | $1.53B | $0.32B | 20.66% |
| 2013-06-30 | $1.52B | $0.31B | 20.25% |
| 2013-03-31 | $1.47B | $0.31B | 21.11% |
| 2012-12-31 | $1.44B | $0.29B | 20.24% |
| 2012-09-30 | $1.39B | $0.28B | 19.80% |
| 2012-06-30 | $1.37B | $0.26B | 18.70% |
| 2012-03-31 | $1.34B | $0.24B | 17.70% |
| 2011-12-31 | $1.30B | $0.23B | 17.27% |
| 2011-09-30 | $1.28B | $0.22B | 17.24% |
| 2011-06-30 | $1.24B | $0.23B | 18.18% |
| 2011-03-31 | $1.19B | $0.22B | 18.52% |
| 2010-12-31 | $1.16B | $0.22B | 18.72% |
| 2010-09-30 | $1.13B | $0.21B | 18.17% |
| 2010-06-30 | $1.09B | $0.19B | 17.38% |
| 2010-03-31 | $1.05B | $0.18B | 17.28% |
| 2009-12-31 | $1.00B | $0.17B | 17.17% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $35.199B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.826B | 25.11 |
| Stryker (SYK) | United States | $146.166B | 32.94 |
| Boston Scientific (BSX) | United States | $145.408B | 41.81 |
| EssilorLuxottica (ESLOY) | France | $115.383B | 0.00 |
| Medtronic (MDT) | Ireland | $112.944B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.849B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.827B | 27.18 |
| GE HealthCare Technologies (GEHC) | United States | $38.715B | 20.08 |
| Terumo (TRUMY) | Japan | $27.980B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.250B | 18.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.811B | 13.89 |
| Insulet (PODD) | United States | $19.347B | 77.04 |
| Baxter (BAX) | United States | $15.818B | 10.29 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.057B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.586B | 32.58 |
| BellRing Brands (BRBR) | United States | $9.323B | 37.51 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.360B | 14.78 |
| ICU Medical (ICUI) | United States | $4.012B | 38.20 |
| Prestige Consumer Healthcare (PBH) | United States | $3.882B | 19.31 |
| Haemonetics (HAE) | United States | $3.691B | 18.01 |
| Envista Holdings (NVST) | United States | $3.413B | 25.42 |
| Perrigo (PRGO) | Ireland | $3.252B | 9.57 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.807B | 18.07 |
| GN Store Nord (GNNDY) | Denmark | $2.585B | 16.58 |
| Neogen (NEOG) | United States | $2.508B | 28.90 |
| LeMaitre Vascular (LMAT) | United States | $2.227B | 54.13 |
| AtriCure (ATRC) | United States | $1.876B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.572B | 27.52 |
| AdaptHealth (AHCO) | United States | $1.416B | 10.11 |
| InMode (INMD) | Israel | $1.410B | 8.48 |
| BioLife Solutions (BLFS) | United States | $1.213B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.205B | 0.00 |
| Owens & Minor (OMI) | United States | $1.124B | 8.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.981B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.843B | 14.87 |
| CeriBell (CBLL) | United States | $0.754B | 0.00 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.623B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.557B | 24.58 |
| Omeros (OMER) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.434B | 0.00 |
| ZimVie (ZIMV) | United States | $0.394B | 33.23 |
| Valneva SE (VALN) | France | $0.355B | 0.00 |
| Quanterix (QTRX) | United States | $0.342B | 0.00 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.18 |
| Biote (BTMD) | United States | $0.306B | 6.71 |
| Sanara MedTech (SMTI) | United States | $0.285B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.25 |
| High Tide (HITI) | Canada | $0.250B | 103.00 |
| Zynex (ZYXI) | United States | $0.245B | 51.20 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 3.18 |
| Aurora Cannabis (ACB) | Canada | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.56 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Brainsway (BWAY) | Israel | $0.192B | 102.30 |
| MacroGenics (MGNX) | United States | $0.188B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.168B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.77 |
| Veru (VERU) | United States | $0.143B | 0.00 |
| Jin Medical (ZJYL) | China | $0.143B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.87 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| INLIF (INLF) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.070B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.069B | 35.33 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.11 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |